Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...

The final report of a phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with ...

Approximately 18,500 persons are diagnosed with malignant glioma in the United States annually. Few studies have investigated the comprehensive economic costs. We reviewed the literature to examine ...

ISPOR 2023 Presentation Shows 33% Lowered Costs with Gleolan Compared to Conventional White Light Surgery Use of Gleolan has been associated with improved imaging complete resection (ICR). In the ...

Tinostamustine, a potential first-in-class therapy, combines bifunctional alkylating activity with pan HDAC inhibition, offering a novel approach for glioblastoma treatment. The FDA's orphan drug ...

Please provide your email address to receive an email when new articles are posted on . Men were significantly younger and underwent surgery faster after diagnosis compared with women. No sex-related ...

The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement in both patient and physician spaces. But following the approval, some ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis. Previous research suggests that platelet-derived growth ...

Pediatric gliomas are also known as childhood gliomas. They’re a type of tumor that can develop in a child’s central nervous system (CNS), including their brain or spinal cord. Gliomas are tumors that ...